Aurora kinase modulators and method of use

Details for Australian Patent Application No. 2009226024 (hide)

Owner Amgen Inc.

Inventors Human, Jason B.; White, Ryan

Agent Shelston IP

Pub. Number AU-B-2009226024

PCT Pub. Number WO2009/117157

Priority 61/070,333 20.03.08 US

Filing date 19 March 2009

Wipo publication date 24 September 2009

Acceptance publication date 12 July 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/437

A61K 31/5025 - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 Antineoplastic agents

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/117157 Priority application(s): WO2009/117157

12 July 2012 Application Accepted

  Published as AU-B-2009226024

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009226025-Device and method for opening blood vessels by pre-angioplasty serration and dilatation of aetherosclerotic plaque

2009226019-Emulsions including a PEG-derivative of tocopherol